Zobrazeno 1 - 7
of 7
pro vyhledávání: '"François Griaud"'
Autor:
Fabian Bickel, François Griaud, Wolfram Kern, Frieder Kroener, Manuela Gritsch, Jérôme Dayer, Samuel Barteau, Blandine Denefeld, Chi-Ya Kao-Scharf, Manuel Lang, Izabela Slupska-Muanza, Carla Schmidt, Matthias Berg, Jürgen Sigg, Lina Boado, Dirk Chelius
Publikováno v:
mAbs, Vol 15, Iss 1 (2023)
ABSTRACTIn this study, we report the isomerization of an aspartic acid residue in the complementarity-determining region (CDR) of crizanlizumab as a major degradation pathway. The succinimide intermediate and iso-aspartic acid degradation products we
Externí odkaz:
https://doaj.org/article/704ad1576cf945d7aab734d00191b085
Autor:
Fabian Bickel, François Griaud, Wolfram Kern, Frieder Kroener, Manuela Gritsch, Jérôme Dayer, Samuel Barteau, Blandine Denefeld, Chi-Ya Kao-Scharf, Manuel Lang, Izabela Slupska-Muanza, Carla Schmidt, Matthias Berg, Jürgen Sigg, Lina Boado, Dirk Chelius
Publikováno v:
mAbs. 15(1)
In this study, we report the isomerization of an aspartic acid residue in the complementarity-determining region (CDR) of crizanlizumab as a major degradation pathway. The succinimide intermediate and iso-aspartic acid degradation products were succe
Autor:
Manuel Lang, Jian-You Chen, Blandine Denefeld, Chi-Ya Kao-Scharf, Matthias Berg, François Griaud, Jerôme Dayer
Publikováno v:
Analytical chemistry. 91(14)
Characterization and monitoring of post-translational modifications (PTMs) are key analytical requirements during the development of biologics. Top and middle-down (MD) approaches aim at capturing a direct snapshot of all proteoforms with their combi
Autor:
Manuel Lang, Héloïse Hensinger, Matthias Berg, François Griaud, Blandine Denefeld, Andrej Winter, Frank Straube, Mirko Sackewitz
Publikováno v:
mAbs
Patent expiration of first-generation biologics and the high cost of innovative biologics are 2 drivers for the development of biosimilar products. There are, however, technical challenges to the production of exact copies of such large molecules. In
Autor:
Peter Haberl, Matthias Berg, François Griaud, Blandine Denefeld, Manuel Lang, Héloïse Hensinger
Publikováno v:
mAbs. 9(5)
Characterization of charge-based variants by mass spectrometry (MS) is required for the analytical development of a new biologic entity and its marketing approval by health authorities. However, standard peak-based data analysis approaches are time-c
Autor:
François Griaud, Anthony D. Whetton, Andrew Pierce, M.B. Gonzalez Sanchez, Doan Duy Hai Tran, Sheela A. Abraham, Mary T. Scott, Tessa L. Holyoake, Teruko Tamura
Publikováno v:
Leukemia. 27(4)
THOC5 is a member of the THO complex that is involved in processing and transport of mRNA. We have shown previously that hematopoietic stem cells have an absolute requirement for THOC5 for survival and that THOC5 is phosphorylated on tyrosine 225 as
Autor:
Anthony D. Whetton, Andrew Pierce, Andrew J.K. Williamson, David N. Potier, Samuel J. Taylor, François Griaud, Elaine Spooncer
Publikováno v:
Griaud, F, Williamson, A J K, Taylor, S, Potier, D N, Spooncer, E, Pierce, A & Whetton, A D 2012, ' BCR/ABL modulates protein phosphorylation associated with the etoposide-induced DNA damage response ', Journal of Proteomics, vol. 77, pp. 14-26 . https://doi.org/10.1016/j.jprot.2012.06.003
BCR/ABL expression is the key characteristic of chronic myeloid leukaemia (CML). The progression of CML is associated with genomic instability. Systematic analysis of DNA damage signalling in the presence of BCR/ABL thus offers opportunities to ident